ducovest

EMMA:OTC-Emmaus Life Sciences Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.071

Change

0.00 (0.00)%

Market Cap

USD 4.40M

Volume

N/A

Analyst Target

USD 24.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-17 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
UCBJF UCB SA

N/A

 USD 34.35B
UCBJY UCB SA ADR

N/A

 USD 34.19B
ARGNF argenx SE

N/A

 USD 31.42B
GNMSF Genmab A/S

N/A

 USD 17.24B
ZLDPF Zealand Pharma A/S

N/A

 USD 9.07B
IVBIY IVBIY

N/A

 USD 9.04B
SBMFF Sino Biopharmaceutical Limited

N/A

 USD 7.35B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

 USD 7.34B
WXXWY WuXi Biologics (Cayman) Inc

N/A

 USD 5.44B
WXIBF WuXi Biologics

N/A

 USD 5.40B

ETFs Containing EMMA

DSI iShares MSCI KLD 400 Soci.. 1,000.00 % 0.25 %

N/A

 N/A
IYG iShares U.S. Financial Se.. 1,000.00 % 0.42 %

N/A

 N/A
IYJ 1,000.00 % 0.42 %

N/A

 N/A
KLD iShares MSCI USA ESG Sele.. 1,000.00 % 0.50 %

N/A

 N/A
QUAL 1,000.00 % 0.15 %

N/A

 N/A
SIZE iShares MSCI USA Size Fac.. 1,000.00 % 0.15 %

N/A

 USD 0.32B
DXF:CA Dynamic Active Global Fin.. 8.59 % 0.86 %

N/A

 CAD 0.01B
QDVH:F iShares S&P 500 Financial.. 6.33 % 0.00 %

N/A

 N/A
SXLF:LSE SPDR S&P U.S. Financials .. 6.27 % 0.00 %

N/A

 N/A
IVFGC 5.90 % 0.00 %

N/A

 N/A
VFH Vanguard Financials Index.. 5.46 % 0.10 %

N/A

 USD 9.95B
ZFIN:CA 5.14 % 0.00 %

N/A

 N/A
BFIN-U:CA 5.12 % 0.00 %

N/A

 N/A
PFI Invesco DWA Financial Mom.. 5.12 % 0.60 %

N/A

 USD 0.06B
QVMP:F PowerShares Global Funds .. 5.10 % 0.00 %

N/A

 N/A
SPHQ Invesco S&P 500® Quality.. 5.08 % 0.19 %

N/A

 N/A
LONG:CA 5.06 % 0.00 %

N/A

 N/A
ZINN:CA 5.05 % 0.00 %

N/A

 N/A
FINZ 4.83 % 0.95 %

N/A

 N/A
SEF ProShares Short Financial.. 4.83 % 0.95 %

N/A

 N/A
SKF ProShares UltraShort Fina.. 4.83 % 0.95 %

N/A

 N/A
DXSP:F Xtrackers - Euro Stoxx 50.. 4.81 % 0.00 %

N/A

 N/A
TPAY 4.68 % 0.00 %

N/A

 N/A
USMC Principal U.S. Mega-Cap E.. 4.65 % 0.12 %

N/A

 USD 2.46B
ZINT:CA 4.39 % 0.00 %

N/A

 N/A
JOYY 4.26 % 0.00 %

N/A

 N/A
FAS Direxion Daily Financial .. 4.25 % 1.04 %

N/A

 N/A
HAU:CA 4.23 % 0.79 %

N/A

 N/A
LINK:CA 4.02 % 0.00 %

N/A

 N/A
QDVB:F iShares IV Public Limited.. 3.91 % 0.00 %

N/A

 N/A
HFT:CA 3.89 % 0.00 %

N/A

 N/A
ETHI:CA Global X Global Sustainab.. 3.85 % 0.74 %

N/A

 CAD 0.11B
GBUY Goldman Sachs Future Cons.. 3.83 % 0.00 %

N/A

 USD 0.06B
XDWF:LSE db x-trackers MSCI World .. 3.72 % 0.00 %

N/A

 N/A
WFIN:LSE SPDR® MSCI World Financi.. 3.71 % 0.00 %

N/A

 N/A
QMJ 3.66 % 0.00 %

N/A

 N/A
RUD:CA RBC Quant US Dividend Lea.. 3.66 % 0.43 %

N/A

 CAD 0.59B
UYG ProShares Ultra Financial.. 3.65 % 0.95 %

N/A

 N/A
ZUQ:CA BMO MSCI USA High Quality 3.63 % 0.32 %

N/A

 CAD 0.87B
DUAL 3.48 % 0.00 %

N/A

 N/A
PWB Invesco Dynamic Large Cap.. 3.37 % 0.55 %

N/A

 N/A
OUSA 3.17 % 0.48 %

N/A

 N/A
TDV 3.04 % 0.00 %

N/A

 N/A
HAU-U:CA 3.00 % 0.00 %

N/A

 N/A
JHMF 2.96 % 0.47 %

N/A

 N/A
PDP Invesco DWA Momentum ETF 2.96 % 0.62 %

N/A

 USD 1.26B
UC99:LSE UBS (Irl) ETF plc - Facto.. 2.74 % 0.00 %

N/A

 USD 1.68B
OPPX 2.37 % 0.00 %

N/A

 N/A
XDEQ:LSE Xtrackers MSCI World Qual.. 2.34 % 0.00 %

N/A

 N/A
IS3Q:F iShares Edge MSCI World Q.. 2.33 % 0.00 %

N/A

 N/A
DGTL:LSE iShares Digitalisation UC.. 2.24 % 0.00 %

N/A

 N/A
VIG Vanguard Dividend Appreci.. 2.12 % 0.06 %

N/A

 N/A
PFM Invesco Dividend Achiever.. 1.92 % 0.54 %

N/A

 USD 0.69B
CGAA:CA CI Global Asset Allocatio.. 1.91 % 0.00 %

N/A

 CAD 0.03B
IGSG:LSE iShares Dow Jones Global .. 1.86 % 0.00 %

N/A

 N/A
CAPS:CA 1.85 % 0.96 %

N/A

 N/A
IUSL:F iShares Dow Jones Global .. 1.85 % 0.00 %

N/A

 N/A
IGSU:LSE iShares Dow Jones Global .. 1.84 % 0.00 %

N/A

 N/A
RUE-U:CA 1.82 % 0.00 %

N/A

 N/A
FBGX 1.79 % 0.00 %

N/A

 N/A
FLGE 1.79 % 0.00 %

N/A

 N/A
XULR:CA 1.72 % 0.00 %

N/A

 N/A
QUS SPDR® MSCI USA Strategic.. 1.54 % 0.15 %

N/A

 N/A
USSG Xtrackers MSCI USA ESG Le.. 1.49 % 0.00 %

N/A

 USD 1.04B
FUSA:F Fidelity UCITS SICAV - Fi.. 1.40 % 0.00 %

N/A

 N/A
FUSD:F Fidelity UCITS SICAV - Fi.. 1.40 % 0.00 %

N/A

 N/A
FUSU:F Fidelity UCITS SICAV - Fi.. 1.40 % 0.00 %

N/A

 N/A
FUSA:LSE Fidelity US Quality Incom.. 1.39 % 0.00 %

N/A

 N/A
FUSI:LSE Fidelity US Quality Incom.. 1.39 % 0.00 %

N/A

 N/A
FUQA:LSE Fidelity US Quality Incom.. 1.39 % 0.00 %

N/A

 N/A
FUSD:LSE Fidelity UCITS SICAV - Fi.. 1.39 % 0.00 %

N/A

 N/A
FUSP:LSE Fidelity US Quality Incom.. 1.39 % 0.00 %

N/A

 N/A
RWCD 1.15 % 0.00 %

N/A

 N/A
UIQM:XETRA 0.87 % 0.00 %

N/A

 N/A
DGIT:LSE iShares Digitalisation UC.. 0.00 % 0.00 %

N/A

 N/A
2B79:F iShares Digitalisation UC.. 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.00% 40% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.00% 40% F 23% F
Trailing 12 Months  
Capital Gain -71.14% 29% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.14% 29% F 13% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -39.17% 12% F 4% F
Dividend Return -39.17% 12% F 4% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.61% 73% C 57% F
Risk Adjusted Return -96.45% 14% F 5% F
Market Capitalization 4.40M 45% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.